ESC Premium Access

Direct factor Xa inhibition prevents cardiac remodeling induced by intermittent hypoxia through PAR-1/2 dual signaling pathway.

Congress Presentation

About the speaker

Miss Mako Shimada

Osaka Medical College, Takatsuki (Japan)
0 follower

4 more presentations in this session

Discussant: Best Posters in tailoring anticoagulant therapy

Thumbnail

Manifestations and outcome of severe warfarin overanticoagulation - the EWA study.

Speaker: Doctor S. Jaakkola (Turku, FI)

Thumbnail

A patient-specific tailored intervention improves INR time in therapeutic range and INR variability in heart failure patients: A randomized controlled trial

Speaker: Associate Professor I. Gotsman (Jerusalem, IL)

Thumbnail

Low TAFI level increases the risk of bleedings in a target INR during long-term warfarin therapy

Speaker: Doctor N. Vorobyeva (Moscow, RU)

Thumbnail

Access the full session

Best Posters 6 - Best Posters in tailoring anticoagulant therapy

Speakers: Miss M. Shimada, Doctor S. Jaakkola, Associate Professor I. Gotsman, Doctor N. Vorobyeva
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb